Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...

Polyrizon (PLRZ) previously announced the initiation of preclinical studies for intranasal Naloxone, a life-saving opioid overdose treatment.

Polyrizon Ltd., a biotech company based in Raanana, Israel, has announced the start of preclinical studies for its intranasal Naloxone product aimed at treating opioid overdoses. Collaborating ...

These preclinical studies mark a step forward in evaluating Polyrizon’s Trap and Target™ (T&T) platform for the intranasal administration of Naloxone, an opioid antagonist designed to rapidly ...

Naloxone has been a cornerstone in the fight against the opioid epidemic, which has seen a surge in fatalities due to synthetic opioids like fentanyl. The intranasal delivery method of Naloxone ...

A toddler in Airway Heights was exposed to fentanyl and revived with Narcan, highlighting the growing opioid crisis and the ...

Port Jefferson stores are now using Narcan nasal spray after a town Chamber of Commerce meeting that included a presentation ...

These preclinical studies mark a step forward in evaluating Polyrizon's Trap and Target™ (T&T) platform for the intranasal administration of Naloxone, an opioid antagonist designed to rapidly reverse ...